Home » Newsletters » BioWorld

BioWorld

Feb. 24, 2000

View Archived Issues

Appointments and Advancements

Cistron In Tentative Deal To Be Acquired For Up To $20M

Angiotech Plans To Raise $82M Publicly To Fund Paclitaxel Work

Other News To Note

Orphan Gets Xyrem On Track With $10M Funding, New Law

Maxim Raises $176M In Public Offering To Launch Maxamine

Incyte Raises $422M Privately To Push Efforts In Genomics

IPO Filings Reach 20 For Year As ViroLogic, Signal Register

Malarial Parasite Yields Clue To Its Chemical Warfare Top Secret: Multiple Drug Resistance Gene